QHP Capital Names Owen Murray as CEO of Bend, CoreRx, and Societal
QHP Capital has announced the appointment of Owen Murray as the new Chief Executive Officer for the recently combined entities of Bend Bioscience, CoreRx, and…
QHP Capital has announced the appointment of Owen Murray as the new Chief Executive Officer for the recently combined entities of Bend Bioscience, CoreRx, and…
Pharmaceutical company CoreRx has completed its acquisition of Societal CDMO. The acquisition was achieved through a tender offer to purchase all issued and outstanding shares of Societal CDMO…
In order to expand its capabilities, CoreRx, Inc. has announced a definitive agreement to acquire Societal CDMO, Inc. (NASDAQ: SCTL), a contract development and manufacturing organisation (CDMO) known…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.